Market Research Logo

Cesca Therapeutics Inc. (KOOL) - Financial and Strategic SWOT Analysis Review


Attention: There is an updated edition available for this report.

Cesca Therapeutics Inc. (KOOL) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Cesca Therapeutics Inc. (Cesca) formerly ThermoGenesis Corp. is a medical equipment company. It researches, develops, and commercializes cell based therapeutics for application in regenerative medicine. Its lead technology platform, SurgWerks is used for the collection, separation, storage and delivery of stem cells from adult tissue sources including cord blood and bone marrow. The company’s CellWerks MXP system is an integrated protocol and equipment with disposables for rapid intra-laboratory use under the direction of a licensed physician. It finds application in bone marrow transplantation and cellular purification from cord blood.

Cesca Therapeutics Inc. Key Recent Developments

Jan 05,2016 Cesca Therapeutics Sponsors First Symposium on Haploidentical Stem Cell Transplantation in India
Nov 16,2015 Cesca Therapeutics Reports First Quarter Fiscal Year 2016 Financial Results
Oct 26,2015 Michael Bruch Appointed Chief Financial Officer of Cesca Therapeutics
Oct 19,2015 Cesca Therapeutics Clinical Laboratory Successfully Facilitates Haploidentical Bone Marrow Transplant Procedure on Unique Pediatric Patient in Need

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Cesca Therapeutics Inc. - Key Facts
Cesca Therapeutics Inc. - Key Employees
Cesca Therapeutics Inc. - Key Employee Biographies
Cesca Therapeutics Inc. - Major Products and Services
Cesca Therapeutics Inc. Pipeline Products by Development Stage
Cesca Therapeutics Inc. - History
Cesca Therapeutics Inc. - Company Statement
Cesca Therapeutics Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Cesca Therapeutics Inc. - Business Description
Cesca Therapeutics Inc. - Corporate Strategy
Cesca Therapeutics Inc. - SWOT Analysis
SWOT Analysis - Overview
Cesca Therapeutics Inc. - Strengths
Strength - Focused Research and Development Activities
Strength - Core Competence: SurgWerks
Strength - Partnership Agreements
Cesca Therapeutics Inc. - Weaknesses
Weakness - Operating Loss Carryforward
Weakness - Declining Cash Reserves
Cesca Therapeutics Inc. - Opportunities
Opportunity - Restructuring Initiatives
Opportunity - Pipeline Products
Opportunity - Strategic Initiatives
Opportunity - Market Potential: Cord Blood Market
Cesca Therapeutics Inc. - Threats
Threat - Stiff Competition
Threat - Rapid Technological Changes
Threat - Tightening Regulations
Threat - Uncertain R&D Outcomes
Cesca Therapeutics Inc. - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Cesca Therapeutics Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Cesca Therapeutics Inc., Medical Equipment, Deals By Type, 2010 to YTD 2016
Cesca Therapeutics Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Cesca Therapeutics Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Cesca Therapeutics Inc., Recent Deals Summary
Section 5 – Company’s Recent Developments
Dec 02, 2015: Cesca Receives Approval for Medicare Coverage
Nov 16, 2015: Cesca Therapeutics Reports First Quarter Fiscal Year 2016 Financial Results
Oct 26, 2015: Michael Bruch Appointed Chief Financial Officer of Cesca Therapeutics
Oct 23, 2015: Cesca Therapeutics to Present Progress on Its CellWerks Product Pipeline at the AABB Conference in Anaheim, California, October 24-27
Oct 19, 2015: Cesca Therapeutics Clinical Laboratory Successfully Facilitates Haploidentical Bone Marrow Transplant Procedure on Unique Pediatric Patient in Need
Sep 28, 2015: Ken Harris to Step Down as President of Cesca Therapeutics
Sep 17, 2015: Cesca Therapeutics Reports Fiscal Year 2015 Results
Sep 15, 2015: Cesca Therapeutics Announces Restructuring Initiative
Jun 23, 2015: Cesca Therapeutics Reports Third Quarter Fiscal 2015 Results
Jun 23, 2015: Cesca Therapeutics Announces Issuance of New U.S. Patent
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Cesca Therapeutics Inc., Key Facts
Cesca Therapeutics Inc., Key Employees
Cesca Therapeutics Inc., Key Employee Biographies
Cesca Therapeutics Inc., Major Products and Services
Cesca Therapeutics Inc. Pipeline Products by Equipment Type
Cesca Therapeutics Inc. Number of Pipeline Products by Development Stage
Cesca Therapeutics Inc. Pipeline Products by Development Stage
Cesca Therapeutics Inc., History
Cesca Therapeutics Inc., Other Locations
Cesca Therapeutics Inc., Subsidiaries
Cesca Therapeutics Inc., Key Competitors
Cesca Therapeutics Inc., Ratios based on current share price
Cesca Therapeutics Inc., Annual Ratios
Cesca Therapeutics Inc., Interim Ratios
Cesca Therapeutics Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Cesca Therapeutics Inc., Medical Equipment, Deals By Type, 2010 to YTD 2016
Cesca Therapeutics Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Cesca Therapeutics Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Cesca Therapeutics Inc., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Cesca Therapeutics Inc. Pipeline Products by Development Stage
Cesca Therapeutics Inc., Performance Chart (2011 - 2015)
Cesca Therapeutics Inc., Ratio Charts
Cesca Therapeutics Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Cesca Therapeutics Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016
Cesca Therapeutics Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Cesca Therapeutics Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report